Filing Details

Accession Number:
0001140361-18-018552
Form Type:
5
Zero Holdings:
No
Publication Time:
2018-04-13 16:50:20
Reporting Period:
2017-12-31
Accepted Time:
2018-04-13 16:50:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1437402 Ardelyx Inc. ARDX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1611311 P. David Rosenbaum C/O Ardelyx, Inc.
34175 Ardenwood Blvd, Suite 200
Fremont CA 94555
Chief Development Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-08-09 2,500 $0.00 4,345 No 4 A Indirect See Footnote
Common Stock Disposition 2017-12-27 300 $6.62 4,045 No 4 S Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Indirect See Footnote
No 4 S Indirect See Footnote
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 66,911 Direct
Common Stock 77,592 Indirect See Footnote
Footnotes
  1. Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) share of Common Stock for each one (1) RSU upon the vesting thereof.
  2. Includes 568 shares acquired under the Issuer's Employee Stock Purchase Plan on August 31, 2017.
  3. The shares are directly held by the Reporting Person's wife.
  4. The shares are directly held by David Paul Rosenbaum and Susan Edelstein Rosenbaum, Trustees of the David Paul Rosenbaum Family Trust.
  5. Includes 270 shares acquired under the Issuer's Employee Stock Purchase Plan on August 31, 2017.